Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | F2 | P00734 | 1/20 | 0.44 |
| ▸ | ELANE | P08246 | 1/20 | 0.43 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | PKM | P14618 | 1/20 | 0.42 |
| ▸ | NPC1 | O15118 | 2/20 | 0.41 |
| ▸ | RAB9A | P51151 | 1/20 | 0.41 |
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GRM2 | Q14416 | 1/20 | 0.40 |
| ▸ | TP53 | P04637 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7762458 | 1.00 | HTT (0.47) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL11411608 | 0.96 | KMT2A (0.44) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL7913960 | 0.96 | HTT (0.49) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL7913964 | 0.96 | HTT (0.49) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL11404298 | 0.95 | KMT2A (0.43) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL11403410 | 0.95 | KMT2A (0.43) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL11418148 | 0.95 | KMT2A (0.43) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL11405326 | 0.92 | KMT2A (0.45) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL7900545 | 0.90 | HTT (0.51) | HTTKMT2ASMN1; SMN2TDP1F2 | |
| SCHEMBL7900546 | 0.90 | HTT (0.51) | HTTKMT2ASMN1; SMN2TDP1F2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-RE37270-E1 | EXCELLENT ELECTRO-OPTIC STEEPNESS AND VIEWING ANGLE COMBINED WITH BIREFRINGENCE FOR USE IN STANDARD DISPLAY CELLS; MIXTURE OF 4-CYANO-3-FLUOROPHENYL BENZOATES, BENZONITRILES, ALKYLPHENYL ESTERS OF CYCLOHEXANE OR PHENYLCARBOXYLIC ACIDS | MERCK PATENT GESELLSCHAFT (DE) | 2001-07-10 | — | — | US | claimed |
| EP-0285617-B1 | LIQUID CRYSTAL PHASE | MERCK PATENT GmbH (DE) | 1991-12-27 | — | — | EP | claimed |
| US-4886621-A | ACCEPTABLE COMBINATION OF THRESHOLD STEEPNESS, VIEWING ANGLE AND TEMPERATURE DEPENDENCE AT LOW THRESHOLD VOLTAGE | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) | 1989-12-12 | — | — | US | claimed |
| US-4783280-A | Liquid crystal mixture | HOFFMANN-LA ROCHE INC. (US) | 1988-11-08 | — | — | US | claimed |
| US-4395350-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1983-07-26 | — | — | US | claimed |
| US-4389329-A | Meterocyclic compounds | HOFFMANN-LA ROCHE INC. (US) | 1983-06-21 | — | — | US | claimed |
| EP-0014885-B1 | CYCLOHEXYLPYRIMIDINES, THEIR PREPARATION AND USE, AS WELL AS LIQUID CRYSTALS MIXTURES AND ELECTRO-OPTICAL APPARATUSES CONTAINING THESE COMPOUNDS AND THEIR PREPARATION | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) | 1983-06-15 | — | — | EP | claimed |
| US-4364838-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1982-12-21 | — | — | US | claimed |
| US-20180208849-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-07-26 | — | — | US | disclosed |
| US-10030198-B2 | Liquid crystal composition and liquid crystal display device | JNC CORPORATION (JP) | 2018-07-24 | — | — | US | disclosed |
| US-20180201836-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-07-19 | — | — | US | disclosed |
| US-20180163138-A1 | LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-06-14 | — | — | US | disclosed |
| US-9976084-B2 | Liquid crystal composition, antioxidant and liquid crystal display device | JNC CORPORATION (JP) | 2018-05-22 | — | — | US | disclosed |
| US-20180127654-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | JNC CORPORATION (JP) | 2018-05-10 | — | — | US | disclosed |
| US-4391731-A | Hydrogenated naphthalenes | HOFFMANN-LA ROCHE INC. (US) | 1983-07-05 | — | — | US | disclosed |
| US-4389329-A | Meterocyclic compounds | HOFFMANN-LA ROCHE INC. (US) | 1983-06-21 | — | — | US | disclosed |
| US-4364838-A | Liquid crystal mixtures | HOFFMANN-LA ROCHE INC. (US) | 1982-12-21 | — | — | US | disclosed |
| EP-0060895-A1 | COMPOSITION FOR LIQUID CRYSTAL COLOR DISPLAY | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1982-09-29 | — | — | EP | disclosed |
| US-4279770-A | Liquid crystal 2,3-dicyano-hydroquinone derivatives | CHISSO CORPORATION (JP) | 1981-07-21 | — | — | US | disclosed |
| US-4273929-A | Heterocyclic compounds | HOFFMANN-LA ROCHE INC. (US) | 1981-06-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180127654-A1 | PIPERIDINE DERIVATIVE, LIQUID CRYSTAL COMPOSITION AND LIQUID CRYSTAL DISPLAY DEVICE | DRD1, PLD1, DRD2 | HTT 2146/4885KMT2A 2766/4885SMN1; SMN2 4549/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.